156 related articles for article (PubMed ID: 6100423)
1. Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa.
Calderwood SB; Gardella A; Philippon AM; Jacoby GA; Moellering RC
Antimicrob Agents Chemother; 1982 Aug; 22(2):266-71. PubMed ID: 6100423
[TBL] [Abstract][Full Text] [Related]
2. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
Jacobs MR; Aronoff SC; Johenning S; Shlaes DM; Yamabe S
Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017
[TBL] [Abstract][Full Text] [Related]
3. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
Chau PY; Ling J; Ng WS
J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993.
Chen HY; Yuan M; Livermore DM
J Med Microbiol; 1995 Oct; 43(4):300-9. PubMed ID: 7562993
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
Chin NX; McElrath MJ; Neu HC
Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
[TBL] [Abstract][Full Text] [Related]
7. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Grace ME; Fu KP; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
[TBL] [Abstract][Full Text] [Related]
8. Incidence of strains producing plasmid determined beta-lactamases among carbenicillin resistant Pseudomonas aeruginosa.
Tirado M; Roy C; Segura C; Reig R; Hermida M; Foz A
J Antimicrob Chemother; 1986 Oct; 18(4):453-8. PubMed ID: 3095304
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Kitzis MD; Ferré B; Coutrot A; Acar JF; Gutmann L
Eur J Clin Microbiol Infect Dis; 1989 Sep; 8(9):783-8. PubMed ID: 2556277
[TBL] [Abstract][Full Text] [Related]
10. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
Sawai T; Tsukamoto K
J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
[TBL] [Abstract][Full Text] [Related]
11. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of inhibition of the carbenicillin-hydrolyzing beta-lactamase PSE-4 by the clinically used mechanism-based inhibitors.
Therrien C; Kotra LP; Sanschagrin F; Mobashery S; Levesque RC
FEBS Lett; 2000 Mar; 470(3):285-92. PubMed ID: 10745083
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus.
Kobayashi S; Arai S; Hayashi S; Sakaguchi T
Antimicrob Agents Chemother; 1989 Mar; 33(3):331-5. PubMed ID: 2786369
[TBL] [Abstract][Full Text] [Related]
14. Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.
Payne DJ; Cramp R; Winstanley DJ; Knowles DJ
Antimicrob Agents Chemother; 1994 Apr; 38(4):767-72. PubMed ID: 8031044
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of tazobactam and piperacillin combination against 224 strains of Pseudomonas aeruginosa according to the production of beta-lactamase].
Thabaut A; Meyran M
Pathol Biol (Paris); 1991 May; 39(5):361-6. PubMed ID: 1652726
[TBL] [Abstract][Full Text] [Related]
16. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
Jacobs MR; Aronoff SC; Johenning S; Yamabe S
J Antimicrob Chemother; 1986 Aug; 18(2):177-84. PubMed ID: 3019984
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
20. Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.
Livermore DM; Yang YJ
J Infect Dis; 1987 Apr; 155(4):775-82. PubMed ID: 3102630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
